Rather than coculturing CD8+ T cells with APCs in-vitro, we developed an in-vivo system by adoptively transferring both the APC (CD45.2) and naïve CD8+ T cell (CD45.1) from tumor-bearing mice into an immunocompetent tumor-bearing host that was treated with radiotherapy (Figure 4A). Here, CD8A is linked to neoplasm.